Items Tagged ‘Head and Neck Cancer’

July 19, 2018

Nimotuzumab in Combination With Concurrent Radiotherapy and Cisplatin Is Active in Locally Advanced SCCHN

By

Nimotuzumab in combination with concurrent radiotherapy and cisplatin provides significant clinical benefits in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). About Head and Neck Cancer Head and neck cancers include a number of different malignant cancers that develop in or around the throat, larynx (voice box), nose, sinuses and […]

View full entry

Tags: EGFR, Head and Neck Cancer, News, Nimotuzumab, treatment


June 14, 2018

University of Colorado Study Suggests new Combination Treatment for Head and Neck Cancer

By

The five-year survival rate for locally-advanced head and neck cancer is only 46 percent, even with treatments including surgery, radiation, chemotherapy and/or genetically targeted treatments such as cetuximab. Often, the problem is that while treatments initially work, cancer evolves to resist treatment. “The question has been how do cancers resist these treatments,” says Sana Karam, MD, PhD, […]

View full entry

Tags: Head and Neck Cancer, News


April 10, 2018

Managing Side Effects From EGFR Inhibitors

By

CancerConnect News: Epidermal Growth Factor Receptor (EGFR) inhibitor drugs are a type of precision cancer medicine commonly used to treat lung, colon, head and neck and other cancers that over express the EGFR.  There are several EGFR inhibitor drugs and these cause similar side effects. The EGFR pathway is a normal biologic pathway found in […]

View full entry

Tags: cetuximab, Colon Cancer, diarrhea, EGFR inhibitors, erbitux, erlotinib, gefitinib, Head and Neck Cancer, iressa, Lung Cancer, News, Panutumamab


April 3, 2018

Spring into Action For Oral, Head, and Neck Cancer Awareness Week!

By

CancerConnect News: As the month of April brings head and neck cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated head and neck cancer information throughout the year. According to statistics from the American Cancer Society (ACS), […]

View full entry

Tags: Head and Neck Cancer, News


February 6, 2018

Guidelines for Human Papilloma Virus Testing in Head and Neck Carcinomas

By

CancerConnect News:  The Centers for Disease Control and Prevention estimates that in the United States, there are more than 16,000 individuals diagnosed with Human Papilloma Virus (HPV)-positive OroPharyngeal Squamous Cell Carcinoma (OPSCC) each year and there has been a significant increase over the past several decades.  Patients with HPV-positive OPSCC tend to be younger males, […]

View full entry

Tags: Head and Neck Cancer, News


January 31, 2018

Depressive Symptoms Linked to Shorter Survival in Patients with Head and Neck Cancer

By

CancerConnect News:  In a study of patients with head and neck cancer, even mild depressive symptoms were associated with poorer overall survival according to a team of doctors from the University of Louisville who published their findings in Cancer the peer-reviewed journal of the American Cancer Society. Globally, head and neck cancer (HNC) comprises the […]

View full entry

Tags: depression, Head and Neck Cancer, News, treatment


January 8, 2018

Head and Neck Cancer Patients at Risk of Cognitive Problems Following Treatment

By

CancerConnect News: Patients who survive head and neck cancer may be more likely to experience declines in mental function according to the results of a recent study. The findings are drawn from cognitive assessments for 80 survivors of head and neck cancer compared to a control group of 40 otherwise similar people who didn’t have […]

View full entry

Tags: chemo brain, Chemotherapy, cognitive function, Head and Neck Cancer, News, radiation